Filing Details

Accession Number:
0001209191-18-025646
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-19 18:48:19
Reporting Period:
2018-04-17
Accepted Time:
2018-04-19 18:48:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1662524 Akcea Therapeutics Inc. AKCA Pharmaceutical Preparations (2834) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
874015 Ionis Pharmaceuticals Inc 2855 Gazelle Court
Carlsbad CA 92010
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-04-17 8,000,000 $0.00 53,447,879 No 4 J Direct
Common Stock Acquisiton 2018-04-17 10,666,666 $18.75 64,114,545 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Direct
No 4 P Direct
Footnotes
  1. Shares issued in satisfaction of the Issuer's obligations to the Reporting Person pursuant to that certain License Agreement, dated March 14, 2018, between the Issuer and the Reporting Person.
  2. Shares purchased pursuant to that certain Stock Purchase Agreement, dated March 14, 2018, between the Issuer and the Reporting Person.